- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Nutrient intake.
Displaying page 1 of 1.
| EudraCT Number: 2011-004811-21 | Sponsor Protocol Number: s53584 | Start Date*: 2011-11-07 |
| Sponsor Name:UZLeuven | ||
| Full Title: The effect of Sildenafil citrate (Viagra ®) on stomach motility, gastric emptying and food intake in healthy volunteers | ||
| Medical condition: study is conducted on healthy volunteers, no medical condition is investigated | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-017193-20 | Sponsor Protocol Number: S51994 | Start Date*: 2010-01-28 |
| Sponsor Name:UZLeuven | ||
| Full Title: Effect of naloxone and methylnaltrexone on satiety, gastric sensitivity, and accommodation to food in healthy volunteers. | ||
| Medical condition: healthy volunteers none; this is a physiological study to investigate the influence of opioid antagonism on gastric sensorimotor function | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-003631-37 | Sponsor Protocol Number: UDC1 | Start Date*: 2017-01-24 |
| Sponsor Name:Universitaire ziekenhuis Leuven | ||
| Full Title: Therapeutic effect of ursodeoxycholic acid on duodenal permeability and meal related sensory motor function in functional dyspepsia patients | ||
| Medical condition: Functional dyspepsia (FD) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-022055-36 | Sponsor Protocol Number: S52478 | Start Date*: 2010-10-04 |
| Sponsor Name:UZLeuven | ||
| Full Title: Intragastric pressure as a determinant of satiation. | ||
| Medical condition: healthy volunteers no medical condition; drugs will be studies because they are known to influence gastric motility. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-003700-31 | Sponsor Protocol Number: ImNuT | Start Date*: 2017-10-11 |
| Sponsor Name:Oslo University Hospital | ||
| Full Title: Effects of nutrition therapy on growth, metabolism and inflammation in immature infants; a double-blind randomized, controlled trial | ||
| Medical condition: To determine whether early and prolonged supply of ARA and DHA improves quality of growth and clinical outcomes in extreme premature infants as compared to our present nutrient supply. By closely a... | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
| Trial protocol: NO (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-005387-10 | Sponsor Protocol Number: ERY-PAO | Start Date*: 2013-03-27 |
| Sponsor Name:Department of hospital Pharmacy, Medical Centre Haaglanden | ||
| Full Title: Effect of Roux-en-Y gstric bypass surgery in morbidly obese patients on Pharmacokinetics of (Acetyl)salicylic acid and Omeprazole. | ||
| Medical condition: Roux-en-Y gastric bypass (RYGB) surgery is a successful treatment for morbid obesity. In this procedure, a small gastric pouch is created. The duodenum is bypassed by connecting the jejunum to this... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-003104-20 | Sponsor Protocol Number: Rimona2011 | Start Date*: 2011-10-06 |
| Sponsor Name:UZLeuven | ||
| Full Title: The effect of Acomplia® (rimonabant) on esophageal sensitivity and gastric accommodation during food intake in healthy volunteers: a single-blind, placebo-controlled study | ||
| Medical condition: study is conducted on healthy volunteers, no medical condition is investigated | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-005740-34 | Sponsor Protocol Number: ESR-14-10698 | Start Date*: 2017-12-08 | ||||||||||||||||
| Sponsor Name:Universitätsklinikum Tübingen | ||||||||||||||||||
| Full Title: Effectiveness of Dapagliflozin + Saxagliptin to revert from a standard basalbolus insulin treatment (BBIT) regimen to a basal supported oral therapy (BOT) in patients with Type 2 Diabetes – a rando... | ||||||||||||||||||
| Medical condition: Diabetes Melitus Type 2 | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
